CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

What Does the Genetic Testing Landscape Look Like?

What Does the Genetic Testing...

How Data Science is Revolutionizing Genomics

How Data Science is Revolutionizing...

Scopus BioPharma Makes New Management Appointment Following the Acquisition of Chief Immunotherapy Firm

Scopus BioPharma Makes New Management...

The Impact of AI and ML in Genomics

The Impact of AI and ML in Genomics

Lykan Bioscience Collaborates with Vineti to Take Cell-Based Therapies from the Clinic to the Market

Lykan Bioscience Collaborates with...

Singapore to grow into a global hub of biotechnology

Singapore to grow into a global hub...

US FDA Award VICO with Therapeutics Orphan-Drug Designation for VO659

US FDA Award VICO with Therapeutics...

An Insight into What Genome is

An Insight into What Genome is

What Does the Genetic Testing Landscape Look Like?

What Does the Genetic Testing...

How Data Science is Revolutionizing Genomics

How Data Science is Revolutionizing...

Scopus BioPharma Makes New Management Appointment Following the Acquisition of Chief Immunotherapy Firm

Scopus BioPharma Makes New Management...

The Impact of AI and ML in Genomics

The Impact of AI and ML in Genomics

Lykan Bioscience Collaborates with Vineti to Take Cell-Based Therapies from the Clinic to the Market

Lykan Bioscience Collaborates with...

Singapore to grow into a global hub of biotechnology

Singapore to grow into a global hub...

US FDA Award VICO with Therapeutics Orphan-Drug Designation for VO659

US FDA Award VICO with Therapeutics...

An Insight into What Genome is

An Insight into What Genome is

Genomics: How Can Employing AI Enhance Healthcare?

Life Sciences Review | Monday, August 23, 2021
Tweet

The most expensive part of drug research is discovery, and improving drug candidate quality increases clinical trial success rates. A genomics-driven approach could enhance disease biology understanding, minimize R&D costs and time to market, and bring more targeted drugs to patients faster.


FREMONT, CA : Genomics is allowing for more personalized treatment by revealing which genes are involved in different medical conditions.  Scientists are using genomics to figure out how Covid-19 spreads and influences the immune system, for example. This information can aid in the development of vaccines.


The data produced by a single human genome sequence ranges from 300GB to 1TB. Over the last decade, technological advancements have driven down the cost of sequencing, a previously expensive procedure, and resulted in an explosion of genomic data. This has opened up a plethora of possibilities for Artificial Intelligence (AI) in space. Companies are attempting to commercialize AI-based genomics solutions to produce improved pharmaceuticals, improve disease detection, and help clinicians identify the most appropriate therapies.


Drug discovery and screening


According to one study, AI in drug discovery will be a 40 billion dollar market by 2027. 


The most expensive part of drug research is discovery, and improving drug candidate quality increases clinical trial success rates. A genomics-driven approach could enhance disease biology understanding, minimize R&D costs and time to market, and bring more targeted drugs to patients faster.


One firm, for example, already has several AI-driven drug candidates in clinical trials. Pharma companies normally invest a significant amount of money in research and development on drugs, many of which will fail in clinical trials, in the hopes of finding one that will excel and achieve blockbuster returns (that is, 1 billion dollars in annual sales).


AI-based drug discovery and screening has the ability to transform the ‘blockbuster’ business model. When combined with genomics, AI can help companies develop medicines for rare diseases, which are far smaller markets that are often overlooked due to high production costs and poor return on investment.


Since biological processes are fundamentally complex, they produce multidimensional data that humans can find difficult to interpret. On the other hand, AI is well-equipped to identify trends in this type of data, and startups are using it to enhance every phase in the drug development process, from biological target identification to preclinical testing.


Weekly Brief

loading
Top 10 Genomics Solution Companies in Europe - 2021
> <
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue

Read Also

Everything You Need to Know About Medical Lab Equipment and their Applications

Everything You Need to Know About Medical Lab Equipment and their Applications

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks To Buy In 2022

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial
How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

The several benefits Of Agricultural Genome Editing

The several benefits Of Agricultural Genome Editing

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/genomics-how-can-employing-ai-enhance-healthcare-nwid-332.html